Literature DB >> 16897338

Hepatic ENPP1 expression is induced in diabetic rabbits.

Philipp Eller1, Kathrin Hochegger, Andreas Wehinger, Ivan Tancevski, Wilfried Schgoer, Andreas Ritsch, Josef R Patsch.   

Abstract

The ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) is an inhibitor of the insulin receptor. Variants of ENPP1 are associated with infantile arterial calcification, obesity, and insulin resistance. To study the functional relevance of this protein in vivo, we cloned rabbit ENPP1 and studied its regulation in experimentally induced diabetes mellitus. We amplified and sequenced the complete coding sequence of rabbit ENPP1 gene out of a liver cDNA library using redundant primers deduced from other species. Next, we performed quantitative PCR of ENPP1 to study the tissue distribution of ENPP1 expression and its regulation in an alloxan-dependent diabetes model. The putative rabbit ENPP1 protein contains 873 amino acids and is highly conserved when compared with human ENPP1 (90% amino acid identity). Particularly high levels of ENPP1 mRNA expression were found in adipose tissue. Quantitative PCR analysis revealed a significant upregulation of ENPP1 transcription in liver (p = 0.025) and brain (p = 0.034) of diabetic rabbits compared with controls. Hepatic ENPP1 expression is induced in diabetic rabbits when compared with controls. This approximately twofold upregulation of ENPP1 mRNA in rabbit liver parallels previous findings in patients with type 2 diabetes mellitus. We provide further molecular information about ENPP1 as a potential pharmacologic target and characterize its regulation in an insulin-dependent diabetes mellitus animal model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16897338     DOI: 10.1007/s00335-006-0028-4

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  19 in total

1.  The K121Q polymorphism in the plasma cell membrane glycoprotein 1 gene predisposes to early myocardial infarction.

Authors:  Georg Endler; Christine Mannhalter; Heike Sunder-Plassmann; Martin Schillinger; Alexandra Klimesch; Markus Exner; Sonja Kapiotis; Susanne Meier; Freja Kunz; Elisabeth Raiger; Kurt Huber; Oswald Wagner; Raute Sunder-Plassmann
Journal:  J Mol Med (Berl)       Date:  2002-11-13       Impact factor: 4.599

2.  Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit.

Authors:  B A Maddux; I D Goldfine
Journal:  Diabetes       Date:  2000-01       Impact factor: 9.461

Review 3.  Drugs producing diabetes through damage of the insulin secreting cells.

Authors:  C C Rerup
Journal:  Pharmacol Rev       Date:  1970-12       Impact factor: 25.468

4.  No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes.

Authors:  H Sakoda; T Ogihara; M Anai; M Funaki; K Inukai; H Katagiri; Y Fukushima; Y Onishi; H Ono; Y Yazaki; M Kikuchi; Y Oka; T Asano
Journal:  Diabetes       Date:  1999-07       Impact factor: 9.461

5.  Plasma cell membrane glycoprotein PC-1. cDNA cloning of the human molecule, amino acid sequence, and chromosomal location.

Authors:  M F Buckley; K A Loveland; W J McKinstry; O M Garson; J W Goding
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

6.  Skeletal muscle content of membrane glycoprotein PC-1 in obesity. Relationship to muscle glucose transport.

Authors:  J F Youngren; B A Maddux; S Sasson; P Sbraccia; E B Tapscott; M S Swanson; G L Dohm; I D Goldfine
Journal:  Diabetes       Date:  1996-10       Impact factor: 9.461

7.  Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification.

Authors:  Frank Rutsch; Nico Ruf; Sucheta Vaingankar; Mohammad R Toliat; Anita Suk; Wolfgang Höhne; Galen Schauer; Mandy Lehmann; Tony Roscioli; Dirk Schnabel; Jörg T Epplen; Alex Knisely; Andrea Superti-Furga; James McGill; Marco Filippone; Alan R Sinaiko; Hillary Vallance; Bernd Hinrichs; Wendy Smith; Merry Ferre; Robert Terkeltaub; Peter Nürnberg
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

8.  Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus.

Authors:  B A Maddux; P Sbraccia; S Kumakura; S Sasson; J Youngren; A Fisher; S Spencer; A Grupe; W Henzel; T A Stewart
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

9.  Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine.

Authors:  A Okawa; I Nakamura; S Goto; H Moriya; Y Nakamura; S Ikegawa
Journal:  Nat Genet       Date:  1998-07       Impact factor: 38.330

10.  Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes.

Authors:  David Meyre; Nabila Bouatia-Naji; Agnès Tounian; Chantal Samson; Cécile Lecoeur; Vincent Vatin; Maya Ghoussaini; Christophe Wachter; Serge Hercberg; Guillaume Charpentier; Wolfgang Patsch; François Pattou; Marie-Aline Charles; Patrick Tounian; Karine Clément; Béatrice Jouret; Jacques Weill; Betty A Maddux; Ira D Goldfine; Andrew Walley; Philippe Boutin; Christian Dina; Philippe Froguel
Journal:  Nat Genet       Date:  2005-07-17       Impact factor: 38.330

View more
  2 in total

Review 1.  The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities.

Authors:  Ira D Goldfine; Betty A Maddux; Jack F Youngren; Gerald Reaven; Domenico Accili; Vincenzo Trischitta; Riccardo Vigneri; Lucia Frittitta
Journal:  Endocr Rev       Date:  2008-01-16       Impact factor: 19.871

2.  Liver ENPP1 protein increases with remission of type 2 diabetes after gastric bypass surgery.

Authors:  Vinko Besic; Richard S Stubbs; Mark T Hayes
Journal:  BMC Gastroenterol       Date:  2014-12-24       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.